StonvexLoading…
StonvexStonvexStonvexCore line items from SOLS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q1 2025 2025-03-31 |
|---|---|---|---|---|
Revenue | $991.00M | $3.89B | $2.90B | $897.00M |
Operating Income | $136.00M | $647.00M | $561.00M | $188.00M |
Net Income | $85.00M | $237.00M | $196.00M | $134.00M |
EPS (Diluted) | $0.53 | $1.49 | Not available | $0.85 |
Total Assets | $5.75B | $5.67B | $5.25B | Not available |
Total Liabilities | $4.28B | $4.30B | $2.07B | Not available |
Cash & Equivalents | $642.00M | $534.00M | $417.00M | $668.00M |
Free Cash Flow OCF − CapEx | $124.00M | $119.00M | $41.00M | $98.00M |
Shares Outstanding | 158.80M | 158.75M | Not available | 158.70M |